ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Solvay and Ineos have signed a definitive agreement to combine their European chlorovinyls businesses into a new company, but the joint venture will be smaller than when it was first proposed more than a year ago. To be called Inovyn, the venture will have annual sales of about $4.0 billion. A year ago sales were expected to be $5.6 billion, but regulators have forced the companies to divest several plants to preserve competition. The original deal gave Ineos the right to buy out Solvay in four to six years. Now, Solvay will definitely exit after three years.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter